Filtered By:
Specialty: Cancer & Oncology
Management: General Practices
This page shows you your search results in order of date.
Order by Relevance | Date
Total 31 results found since Jan 2013.
Thromboembolic disease and cancer: Attitude and practice of general practitioners. A qualitative study
DISCUSSION: The question of etiology of cancer remains unanswered. General practioners would like to be made aware of a common, codified attitude. This raises the question of the applicability of the recommendations. The aim is to avoid misdiagnosing a cancer or delaying a diagnosis, while at the same time, not unnecessarily exposing certain patients to excessive investigations when these are not needed. So, it is time to think about better dissemination of recommendations, tools to help GPs easily finding what they need among the multitude of existing recommendations and tools, to establish better collaboration between ge...
Source: Bulletin du Cancer - September 10, 2023 Category: Cancer & Oncology Authors: Andr éa Barbarit Cyrielle Guyon Elodie Poupin Bernard Fr èche Source Type: research
Drug landscape in patients receiving general outpatient palliative care in Germany: results from a retrospective analysis of 10,464 patients
CONCLUSIONS: Our results support the role of GOPC as an important element in improving pharmacological symptom control and deprescription to improve quality of life of patients at the end of their life.PMID:37596590 | DOI:10.1186/s12904-023-01231-3
Source: Cancer Control - August 18, 2023 Category: Cancer & Oncology Authors: Sven H Loosen Jacqueline Schwartz Steven Grewe Sarah Krieg Andreas Krieg Tom Luedde Yann-Nicolas Batzler Karel Kostev Martin Neukirchen Christoph Roderburg Source Type: research
Results from the PRIMA Trial: Comparison of the STHLM3 Test and Prostate-specific Antigen in General Practice for Detection of Prostate Cancer in a Biopsy-na ïve Population
CONCLUSIONS: The STHLM311 test improved sensitivity but not specificity for detection of GG ≥2 PC in the clinical setting of nonsystematic PC testing in general practice. Further studies are needed to validate a possible benefit of using a higher cutoff for STHLM3 positivity as an entry test for MRI.PATIENT SUMMARY: We used a test called STHLM3 for detection of prostate cancer in general practice and compared its performance to the conventional PSA (prostate-specific antigen) test. We found that STHLM3 test results of 11% or above were not better at selecting men for MRI (magnetic resonance imaging) scans than the PSA te...
Source: Clinical Prostate Cancer - August 3, 2023 Category: Cancer & Oncology Authors: Jacob Freds øe Mads Sandahl Peter Vedsted J ørgen Bjerggaard Jensen Benedicte Parm Ulh øi Michael Borre Karina Dalsgaard S ørensen Bodil Ginnerup Pedersen PRIMA Study Group Source Type: research
The effect of general practice contact on cancer stage at diagnosis in Aboriginal and non-Aboriginal residents of New South Wales
CONCLUSION: Older Aboriginal Australians diagnosed with cancer experience more comorbid conditions and more socioeconomic disadvantage than other Australians, which are negatively related to diagnosis at a local-cancer stage. More frequent GP contact may act to partly offset this among the Aboriginal population of NSW.PMID:37329444 | DOI:10.1007/s10552-023-01727-6
Source: Cancer Control - June 17, 2023 Category: Cancer & Oncology Authors: David Banham David Roder Sandra Thompson Anna Williamson Freddie Bray David Currow Source Type: research
Exposure to weak opioids and risk of gastrointestinal tract cancers: A series of nested case-control studies
CONCLUSION: In this large population-based study, there was no consistent evidence of an association between weak opioids and oesophageal or colorectal cancer risk, but a small increased risk of gastric cancer. Further investigation is required to determine whether this association is causal or reflects residual confounding or confounding by indication.PMID:37117154 | DOI:10.1111/bcp.15759
Source: Clinical Colorectal Cancer - April 28, 2023 Category: Cancer & Oncology Authors: Martin G Houston Úna McMenamin Brian Johnston Ronald D McDowell Carmel M Hughes Peter Murchie Chris R Cardwell Source Type: research
Trends in the full blood count blood test and colorectal cancer detection: a longitudinal, case-control study of UK primary care patient data version 2; peer review: 2 approved, 1 not approved
CONCLUSIONS: Trends in FBC parameters are different between patients with and without colorectal cancer for up to four years prior to diagnosis. Such trends could help earlier identification.PMID:37056715 | PMC:PMC7614427 | DOI:10.3310/nihropenres.13266.2
Source: Cancer Control - April 14, 2023 Category: Cancer & Oncology Authors: Pradeep S Virdee Julietta Patnick Peter Watkinson Jacqueline Birks Tim A Holt Source Type: research
The Colorectal cancer RISk Prediction (CRISP) trial: a randomised controlled trial of a decision support tool for risk-stratified colorectal cancer screening
CONCLUSION: A risk assessment and decision support tool increases risk-appropriate CRC screening in those due screening. The CRISP intervention could commence in people in their fifth decade to ensure people start CRC screening at the optimal age with the most cost-effective test.PMID:37012077 | DOI:10.3399/BJGP.2022.0480
Source: Cancer Control - April 3, 2023 Category: Cancer & Oncology Authors: Jon D Emery Mark A Jenkins Sibel Saya Patty Chondros Jasmeen Oberoi Shakira Milton Kitty Novy Emily Habgood Napin Karnchanachari Marie Pirotta Lyndal Trevena Adrian Bickerstaffe Richard De Abreu Louren ço Anna Crothers Driss Ait Ouakrim Louisa Flander Ja Source Type: research
Protocol for a pragmatic cluster randomised controlled trial assessing the clinical effectiveness and cost-effectiveness of Electronic RIsk-assessment for CAncer for patients in general practice (ERICA)
BMJ Open. 2023 Mar 20;13(3):e065232. doi: 10.1136/bmjopen-2022-065232.ABSTRACTINTRODUCTION: The UK has worse cancer outcomes than most comparable countries, with a large contribution attributed to diagnostic delay. Electronic risk assessment tools (eRATs) have been developed to identify primary care patients with a ≥2% risk of cancer using features recorded in the electronic record.METHODS AND ANALYSIS: This is a pragmatic cluster randomised controlled trial in English primary care. Individual general practices will be randomised in a 1:1 ratio to intervention (provision of eRATs for six common cancer sites) or to usual ...
Source: Cancer Control - March 20, 2023 Category: Cancer & Oncology Authors: Willie Hamilton Luke Mounce Gary A Abel Sarah Gerard Dean John L Campbell Fiona C Warren Anne Spencer Antonieta Medina-Lara Martin Pitt Elizabeth Shephard Marijke Shakespeare Emily Fletcher Adrian Mercer Raff Calitri Source Type: research
Receipt of follow-up care plans on colorectal cancer screening among breast, prostate, and lung cancer survivors
CONCLUSIONS: Receipt of follow-up care plans was associated with greater CRC screening use in breast and prostate cancers. Lung cancer survivors demonstrated lower screening use despite receipt of follow-up care plans.IMPLICATION FOR CANCER SURVIVORS: Patient and provider communication regarding CRC screening recommendation should be included in their follow-up care plans.PMID:36574189 | DOI:10.1007/s11764-022-01309-6
Source: Cancer Control - December 27, 2022 Category: Cancer & Oncology Authors: Meng-Han Tsai Malcolm S Bevel Sydney E Andrzejak Justin X Moore Source Type: research
Which Test Is Best? A Cluster-Randomized Controlled Trial of a Risk Calculator and Recommendations on Colorectal Cancer Screening Behaviour in General Practice
CONCLUSION: An online CRC risk calculator with risk-based screening recommendations increased RAS in high-risk participants and improved screening uptake overall within a 12-month follow-up period. Such tools may be useful for facilitating the uptake of risk-based screening guidelines.PMID:36195055 | DOI:10.1159/000526628
Source: Cancer Control - October 4, 2022 Category: Cancer & Oncology Authors: Lyndal J Trevena Bettina Meiser Llewellyn Mills Timothy Dobbins Danielle Mazza Jon D Emery Judy Kirk Annabel Goodwin Kristine Barlow-Stewart Sundresan Naicker Source Type: research
Antimicrobial drug use and the risk of glioma: A case-control study
Cancer Med. 2022 Sep 6. doi: 10.1002/cam4.5222. Online ahead of print.ABSTRACTBACKGROUND: The use of antibiotics has been associated with increased risks of various cancers. Comprehensive information on the association of antibiotic use with the risk of glioma is lacking.METHODS: We performed a large case-control study based on the Clinical Practice Research Datalink (CPRD) GOLD from the United Kingdom. We identified 4423 glioma cases recorded between 1995 and 2020 and matched them to controls (1:10) on the date of diagnosis (i.e., the index date), age, sex, general practice, and number of years of medical history in the d...
Source: Cancer Control - September 6, 2022 Category: Cancer & Oncology Authors: Tareq M Haedenkamp Michael F Leitzmann Ralf A Linker Christoph Meier Claudia Becker Susan Jick Peter Hau Corinna Seliger Source Type: research
